Zanaflex (tizanidine), a new drug for muscle spasticity

Draxis Health is now marketing Zanaflex (tizanidine), a new drug for muscle spasticity.

Zanaflex will be used to reduce muscle patients with MS, spinal cord injuries, stroke, cerebral palsy, etc.

It's the first new oral drug approved for spasticity since Lioresal (baclofen).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote